Drug Targets – Webinars and Online Events

Webinar
An Introduction to Grating-Coupled Interferometry (GCI)
On-Demand
With unrivaled flexibility and high sensitivity, the WAVE brings label-free quantification to a whole new world of applications, revolutionizing the study of biomolecular interactions.

Webinar
Alzheimer's Disease Pathogenesis: Emerging Role of Microglia
On-Demand
Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.

Webinar
Putting Proteomics at the Heart of Your Multiomics
On-Demand
In this webinar, we host two speakers who will present diverse case studies that will illustrate how multiomics is being used to deepen our understanding of human biology.

Webinar
How To Find Promising Small Molecule Leads
On-Demand
Learn how scientists in the drug discovery field search for the most promising lead compounds. Dr. Claire Hatty from NanoTemper will highlight case studies demonstrating the value of biophysical tools in drug discovery workflows.

Webinar
Genomic Atlas of the Human Proteome and Neurological Disorders
On-Demand
Understanding the tissue-specific genetic architecture of protein levels is instrumental to understand the biology of health and disease.

Webinar
Kidney as a Target: The Important Role of SLCs (Sodium Linked Co-Transporters)
On-Demand
Although the primary focus of the pharmaceutical industry has been identifying the mechanisms of drug elimination and potential drug liability, there is now an increasing focus on the kidney as a therapeutic target.

Webinar
Native Mass Spectrometry and COVID-19: Uncovering Drug Binding and Oligomerization
On-Demand
This webinar will introduce the native MS and lipid nanodisc technique as well as demonstrate how this approach can be used to directly measure the oligomeric state of protein and peptide complexes within intact model lipid bilayers. Ongoing studies on the M2 and E protein will be discussed.
Advertisement